CLAIM #18576 · CVS Health Corp (CVS) · 2025Q3 earnings call · Oct 29, 2025 · due Dec 31, 2026
“we remain confident that our thoughtful approach to our geographic footprint, benefit design and pricing positions us well for another year of recovery.”
David Joyner · CEO
How to check this claim
Look at: Medicare Advantage segment financial recovery/performance, reported annually (e.g., MA operating margin or Medicare segment profitability commentary)
It came true if: Medicare Advantage segment operating margin improves year-over-year for fiscal 2026 vs fiscal 2025
Where: Company 10-K / Q4 2026 earnings release segment disclosures (Healthcare Benefits segment results)
In context
“continues to drive impactful and exceptional results. Aetna is once again the industry leader amongst national payers for 2026 Medicare Advantage Stars Ratings, even with CMS recently announcing that cut points for stars continue to become more challenging. Based on the current membership, we expect over 81% of our Medicare Advantage members will be in plans rated 4 stars or higher with over 63% of them in 4.5 star plans, nearly double the industry average. This result is not just a point of pride, but another proof point that our ability to effectively collaborate across the enterprise allows us to deliver exceptional quality and service, drive down the cost of care and remove friction from the health care system. We are still in the early stages of the 2026 annual enrollment period, but we remain confident that our thoughtful approach to our geographic footprint, benefit design and pricing positions us well for another year of recovery. In my first year as CEO, I have pushed our team to act with urgency and focus as we execute on opportunities to improve our business. This means making thoughtful and difficult decisions, such as exiting our individual exchange business or taking advantage of market opportunities like our acquisition of the Rite Aid assets. In a similar way, as we outlined last quarter, we are moving with urgency to address pressures in Health Care Delivery. During the quarter, we recorded a $5.7 billion goodwill impairment within Health Care Delivery. I want to be clear that this business' performance in the quarter was in line with our most recent expectations. However, our decision during the quarter to temper Oak Street Health Clinic growth over the next few years was the primary reason for recording”
Verify independently
SEC filings for CVS ↗ · Claim quote is verbatim from the 2025Q3 earnings call.